These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 20622384

  • 1. Antibiotic susceptibility pattern of rapidly growing mycobacteria.
    Gayathri R, Therese KL, Deepa P, Mangai S, Madhavan HN.
    J Postgrad Med; 2010; 56(2):76-8. PubMed ID: 20622384
    [Abstract] [Full Text] [Related]

  • 2. In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis.
    Reddy AK, Garg P, Babu KH, Gopinathan U, Sharma S.
    Curr Eye Res; 2010 Mar; 35(3):225-9. PubMed ID: 20373881
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM, Wang SK, Shie DC, Ho SW, Luh KT.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH, Arslan N, Esen N, Özkütük AA.
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [Abstract] [Full Text] [Related]

  • 5. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J, Wang F, Hong CY, Li JL, Liang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [Abstract] [Full Text] [Related]

  • 6. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Wanger A, Boulet B, Plaunt M, Brown BA, Wallace RJ.
    J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
    [Abstract] [Full Text] [Related]

  • 7. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A.
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [Abstract] [Full Text] [Related]

  • 8. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R, Cockrum P, Crider J, Schlech B.
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [Abstract] [Full Text] [Related]

  • 9. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology of Rapidly Growing Mycobacteria Bloodstream Infections.
    Rodriguez-Coste MA, Chirca I, Steed LL, Salgado CD.
    Am J Med Sci; 2016 Mar; 351(3):253-8. PubMed ID: 26992253
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.
    Brown-Elliott BA, Wallace RJ.
    Clin Microbiol Rev; 2002 Oct; 15(4):716-46. PubMed ID: 12364376
    [Abstract] [Full Text] [Related]

  • 13. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL, Bergmann JS, Witebsky FG, Fahle GA, Boulet B, Plaunt M, Brown BA, Wallace RJ, Wanger A.
    J Clin Microbiol; 2000 Feb; 38(2):656-61. PubMed ID: 10655363
    [Abstract] [Full Text] [Related]

  • 14. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, Shen GH.
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [Abstract] [Full Text] [Related]

  • 15. In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.
    Shen Y, Wang X, Jin J, Wu J, Zhang X, Chen J, Zhang W.
    Biomed Res Int; 2018 Mar; 2018():4902941. PubMed ID: 30687747
    [Abstract] [Full Text] [Related]

  • 16. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
    Cremades R, Santos A, Rodríguez JC, Garcia-Pachon E, Ruiz M, Royo G.
    J Chemother; 2008 Feb; 20(1):43-7. PubMed ID: 18343742
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K.
    BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102
    [Abstract] [Full Text] [Related]

  • 18. Drug susceptibility testing of rapidly growing mycobacteria in extrapulmonary tuberculosis.
    Gole GV, Set R, Khan N, Shastri J.
    Indian J Tuberc; 2016 Apr 07; 63(2):119-22. PubMed ID: 27451822
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic resistance in Mycobacterium Abscessus and Mycobacterium Fortuitum isolates from Malaysian patients.
    Jayasingam SD, Zin T, Ngeow YF.
    Int J Mycobacteriol; 2017 Apr 07; 6(4):387-390. PubMed ID: 29171453
    [Abstract] [Full Text] [Related]

  • 20. Localized cutaneous infections in immunocompetent individuals due to rapidly growing mycobacteria.
    Fowler J, Mahlen SD.
    Arch Pathol Lab Med; 2014 Aug 07; 138(8):1106-9. PubMed ID: 25076301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.